In this study, we use data
from a survey conducted in Ukraine among 196 HIV-infected people who inject
drugs, to explore attitudes toward drug addiction and methadone maintenance
therapy (MMT), and intentions to change drug use during incarceration and after
release from prison.
Two groups were recruited: Group 1 (n = 99) was currently incarcerated and Group 2 (n = 97) had been recently released from prison. This paper's key finding is that MMT treatment and addiction recovery were predominantly viewed as mutually exclusive processes. Group comparisons showed that participants in Group 1 (pre-release) exhibited higher optimism about changing their drug use, were less likely to endorse methadone, and reported higher intention to recover from their addiction. Group 2 participants (post-release), however, reported higher rates of HIV stigma.
Structural equation modeling revealed that in both groups, optimism about recovery and awareness of addiction mediated the effect of drug addiction severity on intentions to recover from their addiction.
Two groups were recruited: Group 1 (n = 99) was currently incarcerated and Group 2 (n = 97) had been recently released from prison. This paper's key finding is that MMT treatment and addiction recovery were predominantly viewed as mutually exclusive processes. Group comparisons showed that participants in Group 1 (pre-release) exhibited higher optimism about changing their drug use, were less likely to endorse methadone, and reported higher intention to recover from their addiction. Group 2 participants (post-release), however, reported higher rates of HIV stigma.
Structural equation modeling revealed that in both groups, optimism about recovery and awareness of addiction mediated the effect of drug addiction severity on intentions to recover from their addiction.
Purchase full article at: http://goo.gl/pnocHc
By:
- 1Section of Infectious Diseases, Yale University School of Medicine, 135 College St. Suite 323, New Haven, CT, 06510-2283, USA. maxim.polonsky@yale.edu.
- 2Section of Infectious Diseases, Yale University School of Medicine, 135 College St. Suite 323, New Haven, CT, 06510-2283, USA.
- 3London School of Hygiene and Tropical Medicine, London, UK.
- 4Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- 5Department of Psychiatry, University of California San Francisco School of Medicine, San Francisco, CA, USA.
- 6Ukrainian Institute on Public Health Policy, Kiev, Ukraine.
- 7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
- 8University of Malaya, Centre of Excellence on Research in AIDS (CERiA), Kuala Lumpur, Malaysia.
- AIDS Behav. 2016 Mar 24.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment